TY - JOUR
T1 - Human B cell lines secreting IgM antibody specific for myelin basic protein
AU - Jingwu, Zhang
AU - Lambrechts, Jos
AU - Heyligen, Harry
AU - Vandenbark, Arthur A.
AU - Raus, Jef C.M.
N1 - Funding Information:
The authors wish to thank Dr. Marie-Paule Jacobs and Dr. Luc Kupers for helpful discussion, Mr. Eddy Brepoels for technical assistance and Ms. Paula Henderikx for manuscript preparation. This study was supported in part by the Veterans Administration, and by NIH Grant NS23221.
PY - 1989/9
Y1 - 1989/9
N2 - In this study we describe for the first time the production of stable human B cell lines and clones that secrete IgM antibody specific for human myelin basic protein. The technique based on limiting dilutions of Epstein-Barr virus-transformed peripheral B cells from patients with multiple sclerosis, precluded the need for preselecting or stimulating antigen-specific B cells. Most of the cell lines were stable for at least 6 months in continuous culture and produced 5-12 μg/ml antibody after 2 weeks in culture. The myelin basic protein-specific B cells were surface IgM positive, and occured with a frequency of approximately 1/2500 mononuclear cells in peripheral blood. The successful selection and quantitation of specific B cell clones described here suggests that this technique is well suited for evaluating B cell responses to known and suspected antigens and autoantigens.
AB - In this study we describe for the first time the production of stable human B cell lines and clones that secrete IgM antibody specific for human myelin basic protein. The technique based on limiting dilutions of Epstein-Barr virus-transformed peripheral B cells from patients with multiple sclerosis, precluded the need for preselecting or stimulating antigen-specific B cells. Most of the cell lines were stable for at least 6 months in continuous culture and produced 5-12 μg/ml antibody after 2 weeks in culture. The myelin basic protein-specific B cells were surface IgM positive, and occured with a frequency of approximately 1/2500 mononuclear cells in peripheral blood. The successful selection and quantitation of specific B cell clones described here suggests that this technique is well suited for evaluating B cell responses to known and suspected antigens and autoantigens.
KW - Epstein-Barr virus transformation
KW - Immunoglubin M-secreting B lymphoblastoid cell line
KW - Myelin basic protein
UR - http://www.scopus.com/inward/record.url?scp=0024437089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024437089&partnerID=8YFLogxK
U2 - 10.1016/0165-5728(89)90092-1
DO - 10.1016/0165-5728(89)90092-1
M3 - Article
C2 - 2478580
AN - SCOPUS:0024437089
SN - 0165-5728
VL - 24
SP - 9
EP - 16
JO - Advances in Neuroimmunology
JF - Advances in Neuroimmunology
IS - 1-2
ER -